In a World First, a Patient’s Antibody Cells Were Just Genetically Engineered
B cells are prolific producers of antibodies, but for the first time, scientists have modified them to make other proteins to counteract a serious genetic ..
B cells are prolific producers of antibodies, but for the first time, scientists have modified them to make other proteins to counteract a serious genetic ..
The one-time gene editing fix is meant to halt debilitating pain crises for sickle cell patients, who formerly could only be cured with a risky stem cell ..
An ingestible “digital pill” that measures heart rate and breathing from inside the stomach could detect the warning signs of sleep apnea, cardiac ..
French startup Biomemory is rolling out a credit-card-sized storage device that uses DNA to encode a kilobyte of text data. ..
CAR-T cell therapy harnesses the immune system to attack blood cancers. Six years after approving the first treatment, the FDA is investigating whether ..
The FDA has yet to approve any drugs for life extension. But biotech company Loyal is now a step closer to bringing one to market—for dogs. ..
The gene-editing therapy, called Casgevy, uses Crispr to prevent debilitating pain in patients with sickle cell disease. It also eliminates the need for regular ..
An inventor, molecular biologist, and diagnostic scientist, Dr. Todd cofounded SpeeDx, which serves communities worldwide. And that’s just the beginning. ..
It’s still early days for a novel form of gene therapy called base editing, but this small study in people with extremely high cholesterol shows striking ..
Eli Lilly is about to release Zepbound, a new entrant in the superheated competition for blockbuster weight loss drugs. ..